menu search

Billionaire moderna ceo stéphane bancel pledges stock options worth $355 million to undisclosed charitable causes

Despite a steep Moderna stock crash this year, the longtime biotech executive has amassed a $4.6 billio...

May 24, 2022, 9:12 am

Orgenesis enters second phase of pocare platform rollout; sees recurring revenues from long-term contracts for the next 2-3 years

Orgenesis (NASDAQ:ORGS) Inc, the global biotech company working to unlock the full potential of cell an...

May 24, 2022, 8:09 am

Amyris participates in investor conferences on may 23, 24 and 25, 2022

EMERYVILLE, Calif. , May 23, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's tran...

May 23, 2022, 5:36 pm

Ocugen, inc. to present at h.c. wainwright global investment conference

MALVERN, Pa., May 23, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercial...

May 23, 2022, 7:34 am

Why cellectis' shares rose 22.7% this week

The company bucked the recent downward trend for biotech companies....

May 20, 2022, 7:35 pm

Hot biotech penny stocks to watch as stocks enter bear market

Are these biotech penny stocks on your watchlist right now? The post Hot ...

May 20, 2022, 6:11 pm

Valuation opportunities abound within china's healthcare sector

The health care industry in China is expected to expand rapidly in the coming years with a rapidly aging population, growing infrastructure, and China...

May 20, 2022, 5:24 pm

biotech and delisting risk from china's perspective with wisdomtree

Liqian Ren, Ph.D., and director of modern alpha for WisdomTree, spoke with Dr. Peter Luo, Ph.D....

May 19, 2022, 11:22 pm

Krystal biotech to present additional data on b-vec from the gem-3 phase 3 study at the society for investigative dermatology annual meeting

PITTSBURGH, May 19, 2022 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), the leader in redosable gene therapy, is please...

May 19, 2022, 7:30 pm

7 cheap biotech stocks to buy now

These biotech stocks are speculative, but could potentially blow up in the next couple of years with ne...

May 19, 2022, 6:00 pm

Galapagos: can the company turn around?

Amid the biotech bear market, there are companies that are trading on a deep bargain, yet you should be...

May 19, 2022, 1:18 pm

Moleculin to present at the h.c. wainwright global investment conference

HOUSTON, May 19, 2022 /PRNewswire/ --  Moleculin Biotech, Inc. , (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical comp...

May 19, 2022, 8:05 am

3 oversold biotech stocks to buy now

Looking for oversold biotech stocks? These three have all seen significant drops this year despite prom...

May 19, 2022, 6:40 am

Why tonix pharmaceuticals continued to plummet today

A spot of potentially good news can't stop the investor exodus from the biotech stock....

May 18, 2022, 5:23 pm

Argenx se: again following dutch biotech, prior recommendation near-term gain

Derivatives markets, used by the market-making community to hedge equity market liquidity trade orders, tell by their component structure and prices t...

May 18, 2022, 2:38 pm

Fortress biotech to participate in two upcoming may 2022 investor conferences

MIAMI, May 18, 2022 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on eff...

May 18, 2022, 8:30 am

Is spdr s&p biotech etf (xbi) a strong etf right now?

Smart Beta ETF report for XBI...

May 18, 2022, 7:32 am

Why shares of adaptimmune therapeutics rose 13.4% on tuesday

The clinical-stage biotech saw its shares rise after releasing preclinical data on two of its therapies...

May 17, 2022, 5:03 pm

Celyad oncology to present at the h.c. wainwright global investment conference

MONT-SAINT-GUIBERT, Belgium, May 17, 2022 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext & Nasdaq: CYAD) (the “Company”), a clinical-stage biote...

May 17, 2022, 4:05 pm

Caribou charges ahead on study results

Shares of Caribou Biosciences Inc. ( CRBU , Financial) are up more than 46% since last Thursday, leading the way for several beaten-down biotechs that...

May 17, 2022, 3:07 pm


Search within

Pages Search Results: